麻豆原创

Search

Your search for "therapeutics" gave back 74 results.
Oncternal Therapeutics, Inc - Strategy, SWOT and Corporate Finance Report Summary Oncternal Therapeutics, Inc - Strategy, SWOT and Corporate Finance...
颁补迟补濒辞驳:听
麻豆原创Line
March 2022
Price: USD 175.00
Acorda Therapeutics, Inc - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc - Strategy, SWOT and Corporate Finance Report...
颁补迟补濒辞驳:听
麻豆原创Line
February 2022
Price: USD 175.00
Oncternal Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oncternal Therapeutics, Inc. - Strategy, SWOT and Corporate...
颁补迟补濒辞驳:听
麻豆原创Line
January 2023
Price: USD 175.00
Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report Summary Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance...
颁补迟补濒辞驳:听
麻豆原创Line
December 2022
Price: USD 175.00
Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report Summary Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance...
颁补迟补濒辞驳:听
麻豆原创Line
December 2020
Price: USD 175.00
United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report Summary United Therapeutics Corporation - Strategy, SWOT and Corporate...
颁补迟补濒辞驳:听
麻豆原创Line
December 2022
Price: USD 175.00
CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report Summary CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report, is...
颁补迟补濒辞驳:听
麻豆原创Line
June 2022
Price: USD 175.00
Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance...
颁补迟补濒辞驳:听
麻豆原创Line
January 2023
Price: USD 175.00
Celldex Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Celldex Therapeutics, Inc. - Strategy, SWOT and Corporate Finance...
颁补迟补濒辞驳:听
麻豆原创Line
December 2022
Price: USD 175.00
Novel Prophylactic and Therapeutic Approaches to Manage Staphylococcus aureus (S. aureus) Infections Staphylococcus aureus disease is the leading...
颁补迟补濒辞驳:听
La Merie Publishing
October 2013
Price: USD 662.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Sun Pharmaceuticals is a multinational company and was established by...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Abbott India Limited is a public listed company and a subsidiary of...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
As per NAVADHI 麻豆原创 Research, the global pharmaceutical industry will we worth USD 1.57 trillion by 2023. Amgen Inc. is an American multinational...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
As per NAVADHI 麻豆原创 Research, the global pharmaceutical industry will we worth USD 1.57 trillion by 2023. Bristol-Myers Squibb (BMS) is a global...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00

Contact Us for Custom 麻豆原创 Research Solutions

Clients Who Trust Us

麻豆原创 Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected